Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2026)
Krystal Biotech (KRYS) posted quarterly Exchange Rate Effect of -$1.8 million for Q2 2026, down 272.9% year-over-year from $1.1 million in Q2 2025, and down 37.57% on a QoQ basis from -$1.3 million in Q1 2026.
Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Krystal Biotech has reported Exchange Rate Effect for 5 years, with the latest figure at -$1.8 million in Q2 2026.
- Exchange Rate Effect for Q2 2026 came in at -$1.8 million, down 272.9% year-over-year; the trailing twelve-month figure through Jun 2026 was -$4.1 million (down 545.34% YoY), and the FY2025 annual result was $286000.0, up 162.45% from the prior year.
- Exchange Rate Effect retreated to -$1.8 million in Q2 2026, from -$1.3 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $1.1 million in Q2 2025 and troughed at -$1.8 million in Q2 2026.
- A 5-year average of -$235400.0 and a median of -$41000.0 in 2022 frame the typical range for Exchange Rate Effect.
- The largest YoY upside for Exchange Rate Effect was 2283.33% in 2024 against a maximum downside of 4312.5% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at -$41000.0 in 2022, then slumped by 241.46% to -$140000.0 in 2023, then tumbled by 324.29% to -$594000.0 in 2024, then declined by 7.24% to -$637000.0 in 2025, then tumbled by 187.44% to -$1.8 million in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$1.8 million in Q2 2026, -$1.3 million in Q1 2026, and -$637000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | -1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.83 Mn |
| Jun 30, 2026 | -1.83 Mn |
| Mar 31, 2026 | -1.33 Mn |
| Mar 31, 2026 | -1.33 Mn |
| Dec 31, 2025 | -637,000.00 |
| Dec 31, 2025 | -637,000.00 |
| Sep 30, 2025 | -307,000.00 |
| Sep 30, 2025 | -307,000.00 |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 171,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Dec 31, 2024 | -594,000.00 |
| Dec 31, 2024 | -594,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | -337,000.00 |
| Jun 30, 2024 | -337,000.00 |
| Mar 31, 2024 | 187,000.00 |
| Mar 31, 2024 | 187,000.00 |